Stock A260660 KOREA ARLICO PHARM CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Korea Arlico Pharm Co.,Ltd.

Equities

A260660

KR7260660006

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 01/07/2024 BST 		5-day change 1st Jan Change
4,755 KRW -1.04% Intraday chart for Korea Arlico Pharm Co.,Ltd. -2.16% -16.58%
2023 Korea Arlico Pharm Co.,Ltd. announced that it has received KRW 10 billion in funding CI
2023 Korea Arlico Pharm Co.,Ltd. announced that it expects to receive KRW 10 billion in funding CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on October 6, 2021.
CI
Korea Arlico Pharm Co.,Ltd.'s Equity Buyback announced on October 6, 2021, has closed with 64,000 shares, representing 0.42% for KRW 496.14 million.
CI
Korea Arlico Pharm Co.,Ltd. announces an Equity Buyback for 64,000 shares.
CI
Korea Arlico Pharm Co.,Ltd. authorizes a Buyback Plan.
CI
An unknown buyer acquired 2.5% stake in Korea Arlico Pharm Co.,Ltd. from Hanggu Lee for KRW 3.5 billion.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on March 13, 2020.
CI
Korea Arlico Pharm Co.,Ltd.'s Equity Buyback announced on March 13, 2020, has closed with 102,400 shares, representing 1.07% for KRW 837.77 million.
CI
Korea Arlico Pharm Co.,Ltd. announces an Equity Buyback for 102,040 shares.
CI
Korea Arlico Pharm Co.,Ltd. authorizes a Buyback Plan.
CI
Korea Arlico Pharm Co.,Ltd.'s Equity Buyback announced on June 3, 2019, has expired.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on June 3, 2019.
CI
Korea Arlico Pharm Co.,Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.
CI
Korea Arlico Pharm Co.,Ltd. authorizes a Buyback Plan.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2018.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2018.
CI
Tranche Update on Korea Arlico Pharm Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2018.
CI
Korea Arlico Pharm. Co., Ltd.’s Equity Buyback announced on August 20, 2018 has expired with 87,968 shares, representing 0.92% for KRW 1,076.43 million.
CI
Korea Arlico Pharm Co.,Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.
CI
Korea Arlico Pharm Co.,Ltd. authorizes a Buyback Plan.
CI
Korea Arlico Pharm Co., Ltd. has completed an IPO in the amount of KRW 28.2 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A260660 Stock
  4. News Korea Arlico Pharm Co.,Ltd.
  5. Highlights